论文信息 - A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutations - 字舞流文

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients by phage display is binding to the ACE2-RBD interface and is tolerant to most known recently emerging RBD mutations

S. Dübel | G. Roth | K. Eschke | Thomas Klünemann | T. Schirrmann | M. Hust | A. Frenzel | J. van den Heuvel | U. Rand | P. Riese | Yeonsu Kim | L. Čičin-Šain | Marlies Becker | A. Hermann | P. Kuhn | A. Gerstner | Giulio Russo | F. Bertoglio | D. Meier | H. Garritsen | S. Steinke | Jakob Trimpert | J. Adler | Viola Fühner | M. Z. Chaudhry | M. Scholz | M. Schubert | P. A. Heine | S. Casu | A. Koch | Gustavo Marçal Schmidt Garcia Moreira | Rico Ballmann | E. Wenzel | Maximilian Ruschig | Nora Langreder | Kai-Thomas Schneider | M. Chaudhry | J. Korn | Dorina Schäckermann | Susanne Zock-Emmenthal | Leila Abasi | Kristian Daniel Ralph Roth | J. Trimpert | J. Adler | Ulfert Rand | Andrea Gerstner | Leila Abasi | Kristian Daniel Ralph Roth